JP2020519904A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020519904A5 JP2020519904A5 JP2020511871A JP2020511871A JP2020519904A5 JP 2020519904 A5 JP2020519904 A5 JP 2020519904A5 JP 2020511871 A JP2020511871 A JP 2020511871A JP 2020511871 A JP2020511871 A JP 2020511871A JP 2020519904 A5 JP2020519904 A5 JP 2020519904A5
- Authority
- JP
- Japan
- Prior art keywords
- timp
- igfbp7
- replacement therapy
- concentration
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 19
- 102100029228 Insulin-like growth factor-binding protein 7 Human genes 0.000 claims 17
- 108010008598 insulin-like growth factor binding protein-related protein 1 Proteins 0.000 claims 17
- 102100026262 Metalloproteinase inhibitor 2 Human genes 0.000 claims 16
- 210000002700 urine Anatomy 0.000 claims 13
- 238000012959 renal replacement therapy Methods 0.000 claims 12
- 230000002485 urinary effect Effects 0.000 claims 6
- 238000001631 haemodialysis Methods 0.000 claims 3
- 230000000322 hemodialysis Effects 0.000 claims 3
- 239000007790 solid phase Substances 0.000 claims 3
- 238000011282 treatment Methods 0.000 claims 3
- 238000003018 immunoassay Methods 0.000 claims 2
- 208000009304 Acute Kidney Injury Diseases 0.000 claims 1
- 102000019210 Metalloproteinase inhibitor 2 Human genes 0.000 claims 1
- 108050006602 Metalloproteinase inhibitor 2 Proteins 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000002131 composite material Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 230000007774 longterm Effects 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023052930A JP2023082094A (ja) | 2017-05-07 | 2023-03-29 | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762502728P | 2017-05-07 | 2017-05-07 | |
| US62/502,728 | 2017-05-07 | ||
| PCT/US2018/031425 WO2018208684A1 (en) | 2017-05-07 | 2018-05-07 | Use of insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 in the management of renal replacement therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023052930A Division JP2023082094A (ja) | 2017-05-07 | 2023-03-29 | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020519904A JP2020519904A (ja) | 2020-07-02 |
| JP2020519904A5 true JP2020519904A5 (enExample) | 2021-08-19 |
Family
ID=64105628
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511871A Pending JP2020519904A (ja) | 2017-05-07 | 2018-05-07 | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 |
| JP2023052930A Pending JP2023082094A (ja) | 2017-05-07 | 2023-03-29 | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023052930A Pending JP2023082094A (ja) | 2017-05-07 | 2023-03-29 | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210025875A1 (enExample) |
| EP (1) | EP3621987A4 (enExample) |
| JP (2) | JP2020519904A (enExample) |
| CN (1) | CN110753700A (enExample) |
| WO (1) | WO2018208684A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ628843A (en) | 2008-10-21 | 2016-02-26 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| JP5763098B2 (ja) | 2009-12-20 | 2015-08-12 | アスチュート メディカル，インコーポレイテッド | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
| WO2011162821A1 (en) | 2010-06-23 | 2011-12-29 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| WO2013086359A1 (en) | 2011-12-08 | 2013-06-13 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CA3158996C (en) | 2013-01-17 | 2024-06-04 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN105917229B (zh) | 2013-12-03 | 2019-04-26 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断和预后的方法和组合物 |
| AU2017277305A1 (en) | 2016-06-06 | 2018-12-20 | Astute Medical, Inc. | Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 |
| US11346846B2 (en) | 2017-02-06 | 2022-05-31 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN110709103B (zh) | 2017-04-05 | 2024-02-02 | 机敏医药股份有限公司 | 用于生物学样品中具有改善的性能的timp2的测定法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| WO1992005282A1 (en) | 1990-09-14 | 1992-04-02 | Biosite Diagnostics, Inc. | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| ATE177841T1 (de) | 1991-04-10 | 1999-04-15 | Biosite Diagnostics Inc | ''crosstalk''- oder übersprech-inhibitoren und ihre verwendung |
| EP0579767B1 (en) | 1991-04-11 | 2000-08-23 | Biosite Diagnostics Inc. | Novel conjugates and assays for simultaneous detection of multiple ligands |
| US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| JP5763098B2 (ja) * | 2009-12-20 | 2015-08-12 | アスチュート メディカル，インコーポレイテッド | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
| US20150293085A1 (en) * | 2012-10-31 | 2015-10-15 | Astute Medical, Inc. | Quantitative lateral flow assay |
| WO2016164854A1 (en) * | 2015-04-09 | 2016-10-13 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN108139409B (zh) * | 2015-10-08 | 2020-07-24 | 豪夫迈·罗氏有限公司 | 当在外科手术之前测量时用于预测aki的风险的igfbp7 |
-
2018
- 2018-05-07 CN CN201880040347.5A patent/CN110753700A/zh active Pending
- 2018-05-07 WO PCT/US2018/031425 patent/WO2018208684A1/en not_active Ceased
- 2018-05-07 EP EP18797960.4A patent/EP3621987A4/en active Pending
- 2018-05-07 JP JP2020511871A patent/JP2020519904A/ja active Pending
- 2018-05-07 US US16/611,456 patent/US20210025875A1/en not_active Abandoned
-
2023
- 2023-03-29 JP JP2023052930A patent/JP2023082094A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020519904A5 (enExample) | ||
| Moreau-Gaudry et al. | A simple protein–energy wasting score predicts survival in maintenance hemodialysis patients | |
| JP2008501979A5 (enExample) | ||
| Ma et al. | Uric acid stones, clinical manifestations and therapeutic considerations | |
| JPWO2007046186A1 (ja) | 腹膜機能検査方法、腹膜機能検査装置並びに腹膜機能検査プログラム | |
| JP2023082094A (ja) | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 | |
| JP2002533680A5 (enExample) | ||
| JP2019523889A5 (enExample) | ||
| JP2021502573A5 (enExample) | ||
| JP2012530253A5 (enExample) | ||
| JP2010500535A5 (enExample) | ||
| Wadei et al. | Arterial blood pressure at liver transplant evaluation predicts renal histology in candidates with renal dysfunction | |
| Lone et al. | The role of enhanced recovery after surgery protocols in the development of acute kidney injury following radical cystectomy | |
| JPH11506205A (ja) | 炎症プロセスの病因を決定するための診断方法 | |
| Heuzeroth et al. | Exploratory testing of functional blood oxygenation level dependent-MRI to image the renoprotective effect of Remote Ischaemic PreConditioning during partial nephrectomy | |
| Winkes et al. | Chronic exertional compartment syndrome of the deep posterior lower leg | |
| JP6727660B2 (ja) | 糖尿病性腎症の判定マーカー | |
| Jacoby et al. | Hemothorax | |
| Muttarak et al. | Clinics in diagnostic imaging (97) | |
| Kobayashi et al. | Relationship between muscle strength and rehospitalization in ventricular assist device patients | |
| Holmar et al. | New optical method for estimation of protein bound uremic toxins elimination | |
| JP2016535266A5 (enExample) | ||
| DE60034334D1 (de) | Diagnostisches verfahren für chronische obstruktive lungen krankheit | |
| Castro et al. | 76: Urinary Tract Infection in HTLV-1 Positive Individuals | |
| Wen et al. | Considerations in Controlling for Urine Concentration in Performance of Biomarkers of AKI: PO0248 |